Regeneron Pharmaceuticals, Inc. (REGN) insider activity

Regeneron Pharmaceuticals, Inc. (REGN): 0 insider buys and 1 sale reported in the last 90 days.

A top executive sold $984,195 of REGENERON PHARMACEUTICALS, INC. stock. People sell for many reasons (taxes, a house, diversifying), so a sale means far less than a purchase. (2026-11-03)

Reported	Who	Stock	What	Amount	Source
2026-11-03	McCourt Marion EVP Commercial	REGN REGENERON PHARMACEUTICALS, INC.	Sold	$984,195	SEC filing

Famous investors who hold it

Mason Hawkins (Southeastern Asset Management): 5% of their portfolio at Q2 2026

All insider buys · Legends

TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.